Related Experiment Video

Updated: May 12, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Clinical and epidemiological characteristics of Korean patients with hepatitis C virus genotype 6

Mun Hyuk Seong1, Ho Kil, Jong Yeop Kim

  • 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

Clinical and Molecular Hepatology
|April 18, 2013
PubMed

Insights

Hepatitis C virus (HCV) genotype 6 infections in Korea present unique epidemiological factors and treatment responses compared to genotypes 1 and 2. Continuous monitoring is recommended for this rare HCV genotype.

Area of Science:

  • Hepatology
  • Virology
  • Epidemiology

Background:

  • Hepatitis C virus (HCV) genotype distribution varies globally.
  • In Korea, HCV genotypes 1 and 2 are predominant, with genotype 6 being rare.
  • Understanding genotype-specific characteristics is crucial for effective public health strategies.

Purpose of the Study:

  • To compare clinical and epidemiological features of HCV genotype 6 infections.
  • To contrast these features with those of common HCV genotypes 1 and 2 in Korea.
  • To assess treatment response in patients with HCV genotype 6.

Main Methods:

  • Prospective, multicenter cohort study of 1,173 adult patients.
  • HCV genotype analysis performed on 930 patients.
  • Comparison of clinical and epidemiological parameters between genotype 6 and genotypes 1/2.

Main Results:

  • Nine patients (1.0%) were infected with HCV genotype 6.
  • Genotype 6 patients were younger males with no distinct lab features.
  • Risk factors like tattoos and multiple sexual partners were more prevalent in genotype 6.
  • A sustained virologic response (SVR) was achieved in 67% of genotype 6 patients receiving therapy.

Conclusions:

  • HCV genotype 6 epidemiology and treatment outcomes differ significantly from genotypes 1 and 2.
  • These findings highlight the need for ongoing surveillance of rare HCV genotypes.
  • Tailored management strategies may be necessary for specific HCV genotypes.
Abstract

Keywords:
EpidemiologyGenotypeHCVKoreaTreatment

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...